[{"Assets_0_Q1_USD":220865000.0,"CommonStockSharesOutstanding_0_Q1_shares":65115846.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-17493000.0,"NetIncomeLoss_1_Q1_USD":-19760000.0,"StockholdersEquity_0_Q1_USD":145837000.0,"Ticker":"FATE","CIK":"1434316","name":"FATE THERAPEUTICS INC","OfficialName":"Fate Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3545646272.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]